Acetylsalicylic acid Completed Phase 3 Trials for Coronary Artery Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02266030Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM
NCT01813435GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation